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Klebsiella species are clinically important gram-negative germs,
because of (i) their tendency to develop antibiotic resistance
and (ii) their association with fatal outcome (1). Early initia-
tion of an adequate antibiotic regimen has been shown to
improve an individuals’ prognosis (2). Therefore, it is cru-
cial to identify these risk factors associated with worse out-
come as soon as possible aiming to lose no time to appropri-
ate management (3-5). In the October issue of the Journal
we read with major interest the article by Kang and collea-
gues studying clinical features, treatment outcomes, and
clinical outcomes in patients with K. pneumoniae. A total of
377 patients with K. pneumoniae bacteremia, of which 191
were defined as community-acquired and 186 as nosocomi-
al, were analyzed (6). This study found mortality rates due
to nosocomial infection to be more than twice as high as the
mortality rates due to community-acquired infection (6).
Next, a multitude of risk factors were found to be indepen-
dently associated with 30-day mortality (6).
First, we would like to congratulate the authors for their
considerable efforts made in gathering one of the largest data-
bases of both community-acquired and nosocomial K. pneu-
monia bacteremia. 
Second, while this study adds substantial support to earli-
er reports, one specific concern was raised. Strongly signifi-
cant differences were observed in terms of demographic char-
acteristics and underlying conditions of patients between
the two study groups. The group with nosocomial infection
was sicker, had more prior antibiotic exposure, received inap-
propriate antibiotics (both empiric and definitive therapy)
more often, showed antibiotic resistance more frequently,
and underwent more invasive procedures compared to the
group with community-acquired infection. This may have
biased the results. In a study concerning clinical outcomes
in patients with Methicillin-Susceptible (MSSA) versus Me-
thicillin-Resistant Staphylococcus aureus (MRSA), Soriano and
colleagues compared 225 episodes of MSSA bacteremia with
683 episodes of MRSA bacteremia (7). In this cohort, the
latter was also more severely ill and thus had, higher intrin-
sic mortality rate (6, 7). Therefore, Soriano et al. composed
163 matched pairs of MSSA and MRSA bacteremia based
on pre-existing comorbidities, prognosis of underlying dis-
eases, and length of stay prior to onset of bacteremia. Nev-
ertheless, there were still more comorbidity factors and a
higher rate of shock and related mortality noted in the MR-
SA group. After performing logistic regression analysis, me-
thicillin resistance was no longer independently associated
with shock and mortality (7). Based on this finding, the au-
thors concluded that cohort studies tend to magnify the rela-
tionship of MRSA with clinical markers of microbial patho-
genicity by inadequately controlling for underlying condi-
tions (7). According to the study by Kang and colleagues, it
can be presumed that the authors potentially have overesti-
mated the pathogenic impact of nosocomial K. pneumonia
bacteremia (8). To overcome this difficulty, a matched cohort
study design can provide a satisfying alternative (9). Doing
so, and by sophisticated adjustment for the severity of illness,
risk factors directly attributable to either community-acqu-
ired or nosocomial K. pneumoniae bacteremia could be iden-
tified.
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